Characterizing molecular probes for diffusion measurements in the brain

Gurjinder Kaur1, Sabina Hrabetova, David N Guilfoyle

  • 1Center for Advanced Brain Imaging, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, United States.

Insights

This study evaluated molecular probes for brain diffusion imaging. Neither tetramethylammonium (TMA+) nor hexafluoroantimonate (SbF(6)-) proved ideal, highlighting challenges in combined magnetic resonance (MR) and real-time iontophoresis (RTI) diffusion measurements.

Area of Science:

  • Neuroscience
  • Biophysics
  • Medical Imaging

Background:

  • Magnetic resonance (MR) diffusion imaging is standard for brain diffusion evaluation.
  • MR struggles to differentiate extracellular and intracellular signals.
  • Real-time iontophoresis (RTI) exclusively detects extracellular diffusion.

Purpose of the Study:

  • To define requirements for molecular probes used in both MR and RTI.
  • To assess tetramethylammonium (TMA+) and hexafluoroantimonate (SbF(6)-) as potential probes.

Main Methods:

  • Evaluated probe properties in rat neocortical slices (normal and ischemic).
  • Assessed probes in solutions and agarose gel.
  • Examined stability, cellular interaction, and signal detection for MR and RTI.

Main Results:

  • TMA+ was stable but rapidly accumulated intracellularly.
  • SbF(6)- showed limited cell penetration but was unstable, especially under ischemia and heat, and reduced extracellular volume.
  • Neither probe met all ideal criteria for combined MR and RTI diffusion studies.

Conclusions:

  • Existing probes like TMA+ and SbF(6)- have limitations for combined MR and RTI brain diffusion imaging.
  • Understanding these probe limitations aids interpretation of existing MR data.
  • Further development of dual-modal diffusion probes is needed.